Prescribing Information Summary of Product Characteristics
digoxin immune fab digifab logo DIGIFab

This is a promotional website fully funded and created by SERB Pharmaceuticals for UK Healthcare Professionals only.

Order DIGIFab®
01865 904141

Risk Factors

Raise the Index of Clinical Suspicion

  • Patients undergoing digoxin therapy who exhibit risk factors for digoxin toxicity should be closely monitored so that any signs of poisoning are identified early to ensure timely treatment.1

Risk factors for potentially life-threatening digoxin toxicity

digoxin toxicity risk factors renal impairment image

Decreased Renal Function1,2

expand icon
digoxin toxicity risk factors renal impairment image

Renal impairment can lead to increased digoxin levels, as digoxin is primarily eliminated by the kidneys1,2

collapse icon
digoxin toxicity risk factors drug interactions image

Multiple Concomitant Medications2

expand icon
digoxin toxicity risk factors drug interactions image

Many medications can cause pharmacokinetic and pharmacodynamic interactions with digoxin or a decrease in renal function2

collapse icon
digoxin toxicity risk factors age image

Advanced Age and Medical Illness2-4

expand icon
digoxin toxicity risk factors age image

Older patients are more likely to have decreased renal function and to be taking interacting concomitant medications2,3; advanced heart failure is also associated with decreased renal function4

collapse icon
digoxin toxicity risk factors electrolyte imbalance image

Electrolyte Imbalance1,5

expand icon
digoxin toxicity risk factors electrolyte imbalance image

Certain electrolyte imbalances (e.g., hypokalaemia, hypercalcemia, hypomagnesemia) can increase sensitivity to digoxin effects1,5,*

*In patients with toxicity from acute ingestion, hyperkalaemia is associated with high mortality1

collapse icon
digoxin toxicity risk factors fluids image

Fluid Status1

expand icon
digoxin toxicity risk factors fluids image

Fluid loss or poor fluid intake can lead to electrolyte imbalance1

collapse icon
lines
digoxin toxicity signs immediate intervention image

Any ONE
should raise clinical suspicion for
LIFE-THREATENING DIGOXIN TOXICITY1,3

digoxin toxicity rapid treatment image

For known (or strongly suspected) life-threatening digoxin toxicity or cardiac glycoside poisoning, think R.A.P.I.D.1,2,5

Recognize. Act. Promptly Infuse DIGIFab®.

View Efficacy Data

* DIGIFab® is indicated for the treatment of known (or strongly suspected) life-threatening digoxin toxicity or cardiac glycoside poisoning associated with ventricular arrhythmias or bradyarrhythmias unresponsive to atropine where measures beyond withdrawal of digoxin or cardiac glycosides and correction of serum electrolyte abnormalities are considered necessary.5

digoxin-immune-fab-digifab-neutralizes-image

DIGIFab® rapidly neutralises free digoxin to resolve the cardiotoxic effects and other clinical manifestations of life-threatening digoxin toxicity5,6

See How DIGIFab® Works

References

  1. Levine MD, O’Connor A. Digitalis (cardiac glycoside) poisoning. UpToDate. Updated January 2020. https://www.uptodate.com/contents/digitalis-cardiac-glycoside-poisoning. Accessed December 2024.
  2. Wofford JL, Ettinger WH. Risk factors and manifestations of digoxin toxicity in the elderly. Am J Emerg Med. 1991;9(2):11-15.
  3. Goldberger AL, Traub SJ. Cardiac arrhythmias due to digoxin toxicity. UpToDate. Updated January 2020. https://www.uptodate.com/contents/cardiac-arrhythmias-due-to-digoxin-toxicity. Accessed December 2024. 
  4. McAlister FA, Ezekowitz A, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109(8):1004-1009.
  5. DIGIFab Digoxin Immune Fab (ovine) Summary of Product Characteristics (SmPC).
  6. Ward SB, Sjostrom L, Ujhelyi MR. Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus Digibind. Ther Drug Monit. 2000;22(5):599-607.